Discovery of a Potent and Orally Bioavailable Estrogen Receptor Degrader-Antagonists

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(07): 0727
DOI: 10.1055/s-0042-1752711

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Ferdinand H. Lutter (Janssen Pharmaceutica)

breast cancer treatment - zwitterion - oral bioavailability

Article published online:
16 June 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany